Article ID: CBB000932013

Pharmacovigilance and the Missing Denominator: The Changing Context of Pharmaceutical Risk Mitigation. (2007)

unapi

Daemmrich, Arthur Alfred (Author)


Pharmacy in History
Volume: 49
Pages: 61--75


Publication Date: 2007
Edition Details: AIHP Kremers Award Address 2006
Language: English

Description On the regulation of pharmaceuticals, the changing healthcare system, and practitioners' control over safety laws.


Citation URI
https://data.isiscb.org/isis/citation/CBB000932013/

Similar Citations

Book Daemmrich, Arthur; Radin, Joanna; (2007)
Perspectives on Risk and Regulation: The FDA at 100 (/isis/citation/CBB000930536/)

Book Mikkael A. Sekeres; (2022)
Drugs and the FDA: Safety, Efficacy, and the Public's Trust (/isis/citation/CBB614307145/)

Book Hilts, Peter J.; (2003)
Protecting America's Health: The FDA, Business, and One Hundred Years of Regulation (/isis/citation/CBB000502240/)

Book Shorter, Edward; (2009)
Before Prozac: The Troubled History of Mood Disorders in Psychiatry (/isis/citation/CBB000952059/)

Book Carpenter, Daniel; (2010)
Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA (/isis/citation/CBB001020607/)

Article Hicks, Jesse; (2010)
The Pursuit of Sweet: A History of Saccharin (/isis/citation/CBB001021092/)

Book Daemmrich, Arthur A.; (2004)
Pharmacopolitics: Drug Regulation in the United States and Germany (/isis/citation/CBB000501505/)

Article Sismondo, Sergio; (2004)
Pharmaceutical Maneuvers (/isis/citation/CBB000651081/)

Article Carstairs, Catherine; (2008)
Expertise, Health, and Popular Opinion: Debating Water Fluoridation, 1945--80 (/isis/citation/CBB001030863/)

Article Reinhardt, Carsten; (2010)
Regulierungswissen und Regulierungskonzepte (/isis/citation/CBB001022052/)

Article MacLeod, Roy; (2007)
Preface (/isis/citation/CBB000830070/)

Thesis Schwartz, Jason Lee; (2012)
External Factors: Advisory Committees, Regulation, and American Public Health, 1962--1999 (/isis/citation/CBB001567388/)

Thesis Boyle, Eric W.; (2007)
The Boundaries of Medicine: Redefining Therapeutic Orthodoxy in an Age ofReform (/isis/citation/CBB001560941/)

Article Kahn, Jonathan; (2008)
Exploiting Race in Drug Development: BiDil's Interim Model of Pharmacogenomics (/isis/citation/CBB000953517/)

Article Jessica Epstein; (2018)
Drugs that Shaped the FDA: From Elixir Sulfanilamide to Thalidome (/isis/citation/CBB942814659/)

Authors & Contributors
Daemmrich, Arthur Alfred
Epstein, Jessica
Mikkael A. Sekeres
Sismondo, Sergio
Schwartz, Jason Lee
Tobbell, Dominique Avril
Concepts
Pharmaceutical industry
Legislative and administrative regulations
Medicine and government
Science and politics
Science and law
Science and government
Time Periods
20th century
20th century, late
21st century
20th century, early
19th century
Places
United States
Sweden
Germany
Canada
Institutions
United States. Food and Drug Administration (USFDA)
American Medical Association
United States. Food and Drug Administration
National Institute of Health (U.S.)
Centers for Disease Control (U.S.)
Comments

Be the first to comment!

{{ comment.created_by.username }} on {{ comment.created_on | date:'medium' }}

Log in or register to comment